TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Good Schools Study: Cluster Randomised Controlled Trial of a Program to Prevent Violence Against Children in Schools
Brief Summary: The purpose of this study is to determine whether use of the Good Schools Toolkit is effective in reducing violence against children in primary schools.


Options:
A: Arm Label: Group problem management plus; Type: EXPERIMENTAL; Interventions: Behavioral: Group problem management plus | Arm Label: Enhanced treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group problem management plus, Behavioral: Enhanced treatment as usual | Intervention Type: BEHAVIORAL; Name: Group problem management plus; Assigned to Arm(s): Enhanced treatment as usual, Group problem management plus | Intervention Type: BEHAVIORAL; Name: Enhanced treatment as usual; Assigned to Arm(s): Enhanced treatment as usual
B: Arm Label: "Parents Make the Difference"; Type: EXPERIMENTAL; Interventions: Behavioral: Parents Make the Difference | Arm Label: Waitlist Control; Type: OTHER; Interventions: Behavioral: Parents Make the Difference | Intervention Type: BEHAVIORAL; Name: Parents Make the Difference; Assigned to Arm(s): "Parents Make the Difference", Waitlist Control
C: Arm Label: Good School Toolkit; Type: EXPERIMENTAL; Interventions: Behavioral: Good School Toolkit | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Good School Toolkit; Assigned to Arm(s): Good School Toolkit
D: Arm Label: Comparison; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: HIV prevention intervention; Type: EXPERIMENTAL; Interventions: Behavioral: HIV prevention intervention | Intervention Type: BEHAVIORAL; Name: HIV prevention intervention; Assigned to Arm(s): HIV prevention intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pilot Study on Mindfulness for Tobacco and Alcohol in University Students
Brief Summary: A. The study follows a randomized controlled design with approximately 60 smokers with a history of alcohol abuse age 18-29. The study will compare a 7-week mindfulness intervention to a matched 7-week education intervention to evaluate intervention effect on smoking cessation and reduction in alcohol use. The primary hypothesis is that the mindfulness intervention will yield statistically significantly higher smoking abstinence than controls as measured by carbon monoxide breath test and Time Line Follow Back at at the end of treatment (2-weeks post smoking cessation attempt).


Options:
A: Arm Label: IIDEA; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Integrated Intervention for Dual Problems and Early Action | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Integrated Intervention for Dual Problems and Early Action; Assigned to Arm(s): IIDEA
B: Arm Label: Mindfulness Training for Smokers; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mindfulness Training for Smokers | Arm Label: Interactive Learning for Smokers; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Interactive Learning for Smokers | Intervention Type: BEHAVIORAL; Name: Mindfulness Training for Smokers; Assigned to Arm(s): Mindfulness Training for Smokers | Intervention Type: BEHAVIORAL; Name: Interactive Learning for Smokers; Assigned to Arm(s): Interactive Learning for Smokers
C: Arm Label: Mindfulness-Oriented Recovery Enhancement; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-Oriented Recovery Enhancement | Arm Label: Conventional Support Group (SG); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional Support Group (SG) | Intervention Type: BEHAVIORAL; Name: Mindfulness-Oriented Recovery Enhancement; Assigned to Arm(s): Mindfulness-Oriented Recovery Enhancement | Intervention Type: BEHAVIORAL; Name: Conventional Support Group (SG); Assigned to Arm(s): Conventional Support Group (SG)
D: Arm Label: Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as Usual | Arm Label: IPGT; Type: EXPERIMENTAL; Interventions: Behavioral: IPGT | Intervention Type: BEHAVIORAL; Name: IPGT; Assigned to Arm(s): IPGT | Intervention Type: BEHAVIORAL; Name: Treatment as Usual; Assigned to Arm(s): Treatment as Usual

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pilot Study on Mindfulness for Tobacco and Alcohol in University Students
Brief Summary: A. The study follows a randomized controlled design with approximately 60 smokers with a history of alcohol abuse age 18-29. The study will compare a 7-week mindfulness intervention to a matched 7-week education intervention to evaluate intervention effect on smoking cessation and reduction in alcohol use. The primary hypothesis is that the mindfulness intervention will yield statistically significantly higher smoking abstinence than controls as measured by carbon monoxide breath test and Time Line Follow Back at at the end of treatment (2-weeks post smoking cessation attempt).


Options:
A: Arm Label: Mindfulness Training for Smokers; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mindfulness Training for Smokers | Arm Label: Interactive Learning for Smokers; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Interactive Learning for Smokers | Intervention Type: BEHAVIORAL; Name: Mindfulness Training for Smokers; Assigned to Arm(s): Mindfulness Training for Smokers | Intervention Type: BEHAVIORAL; Name: Interactive Learning for Smokers; Assigned to Arm(s): Interactive Learning for Smokers
B: Arm Label: WebQuit study group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: WebQuit study group | Arm Label: WebQuit control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: WebQuit control group | Intervention Type: BEHAVIORAL; Name: WebQuit study group; Assigned to Arm(s): WebQuit study group | Intervention Type: BEHAVIORAL; Name: WebQuit control group; Assigned to Arm(s): WebQuit control group
C: Arm Label: ACT; Type: EXPERIMENTAL; Interventions: Behavioral: ACT | Arm Label: CBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CBT | Intervention Type: BEHAVIORAL; Name: ACT; Assigned to Arm(s): ACT | Intervention Type: BEHAVIORAL; Name: CBT; Assigned to Arm(s): CBT
D: Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Control | Arm Label: Acceptance and Commitment Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Acceptance and Commitment Therapy | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: Acceptance and Commitment Therapy; Assigned to Arm(s): Acceptance and Commitment Therapy

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cardiovascular Rehabilitation Early After Stroke Using Feedback-controlled Robotics-assisted Treadmill Exercise: A Randomised Controlled Pilot Trial
Brief Summary: The propose of this study is to evaluate the feasibility and the clinical efficiency of feedback-controlled robotics-assisted treadmill exercise (RATE) technology for cardiovascular rehabilitation early after stroke. The investigators hypothesize that feedback-controlled RATE might be suitable and effective to improve cardiovascular fitness and functional carryover in non-ambulatory individuals with sub-acute stroke.


Options:
A: Arm Label: Stride Management Assist (SMA) System; Type: EXPERIMENTAL; Interventions: Device: The Stride Management Assist (SMA) System | Arm Label: Impairment based therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Impairment based therapy | Intervention Type: DEVICE; Name: The Stride Management Assist (SMA) System; Assigned to Arm(s): Stride Management Assist (SMA) System | Intervention Type: OTHER; Name: Impairment based therapy; Assigned to Arm(s): Impairment based therapy
B: Arm Label: Lokomat Group; Type: EXPERIMENTAL; Interventions: Other: Robot-assisted gait therapy | Arm Label: conventional gait training group; Type: ACTIVE_COMPARATOR; Interventions: Other: conventional gait training | Intervention Type: OTHER; Name: Robot-assisted gait therapy; Assigned to Arm(s): Lokomat Group | Intervention Type: OTHER; Name: conventional gait training; Assigned to Arm(s): conventional gait training group
C: Arm Label: RT in sequential combination with dCIT; Type: EXPERIMENTAL; Interventions: Behavioral: RT in sequential combination with dCIT | Arm Label: Distributed Constraint-Induced Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Distributed Constraint-Induced Therapy | Arm Label: Robot-Assisted Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Robot-Assisted Therapy | Arm Label: Dose-matched control therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Dose-matched control therapy | Intervention Type: BEHAVIORAL; Name: RT in sequential combination with dCIT; Assigned to Arm(s): RT in sequential combination with dCIT | Intervention Type: BEHAVIORAL; Name: Distributed Constraint-Induced Therapy; Assigned to Arm(s): Distributed Constraint-Induced Therapy | Intervention Type: BEHAVIORAL; Name: Robot-Assisted Therapy; Assigned to Arm(s): Robot-Assisted Therapy | Intervention Type: BEHAVIORAL; Name: Dose-matched control therapy; Assigned to Arm(s): Dose-matched control therapy
D: Arm Label: FC-RATE; Type: EXPERIMENTAL; Interventions: Device: Feedback-controlled robotics-assisted treadmill exercise | Arm Label: RATE; Type: ACTIVE_COMPARATOR; Interventions: Device: Robotics-assisted treadmill exercise | Intervention Type: DEVICE; Name: Feedback-controlled robotics-assisted treadmill exercise; Assigned to Arm(s): FC-RATE | Intervention Type: DEVICE; Name: Robotics-assisted treadmill exercise; Assigned to Arm(s): RATE

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Study to Examine the Role of Probiotics for Improving Outcomes of C. Difficile
Brief Summary: The purpose of this study is to determine whether a probiotic, when used together with standard treatment, is effective in reducing duration of symptoms and preventing recurrence of infection in older adults with a first episode of C. difficile infection.


Options:
A: Arm Label: Probiotic; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotic | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotic; Assigned to Arm(s): Probiotic | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vancomycin | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: PAR-101/OPT-80 | Intervention Type: DRUG; Name: PAR-101/OPT-80; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Vancomycin; Assigned to Arm(s): 1
C: Arm Label: LFF571 (POC); Type: EXPERIMENTAL; Interventions: Drug: LFF571 | Arm Label: Vancomycin (POC); Type: ACTIVE_COMPARATOR; Interventions: Drug: Vancomycin (POC) | Arm Label: LFF571 Dose level 1 (cohort 2); Type: EXPERIMENTAL; Interventions: Drug: LFF571 | Arm Label: LFF571 Dose level 2 (cohort 2); Type: EXPERIMENTAL; Interventions: Drug: LFF571 | Arm Label: LFF571 Dose level 3 (cohort 2); Type: EXPERIMENTAL; Interventions: Drug: LFF571 | Arm Label: LFF571 Dose level 4 (cohort 2); Type: EXPERIMENTAL; Interventions: Drug: LFF571 | Intervention Type: DRUG; Name: LFF571; Assigned to Arm(s): LFF571 (POC), LFF571 Dose level 1 (cohort 2), LFF571 Dose level 2 (cohort 2), LFF571 Dose level 3 (cohort 2), LFF571 Dose level 4 (cohort 2) | Intervention Type: DRUG; Name: Vancomycin (POC); Assigned to Arm(s): Vancomycin (POC)
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Nitazoxanide | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vancomycin | Intervention Type: DRUG; Name: Nitazoxanide; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Vancomycin; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Investigating the Safety of Morphine and Ibuprofen in Children Post-adenotonsillectomy for Obstructive Sleep Apnea
Brief Summary: Every year thousands of young children with obstructive sleep apnea undergo surgery which requires them to be prescribed pain medication. The current standard in North America is administration of opioids, mainly codeine or morphine; however in many areas of the world including Canada, nonsteroidal anti-inflammatory medications such as ibuprofen are used. Some North American surgeons are uncertain regarding the potential of ibuprofen to increase bleeding following surgery. The results of research studies have been inconclusive overall. Due to recent codeine fatalities in children following adenotonsillectomy, codeine has been removed from the formulary at many Pediatric institutions. Some surgeons have begun to use oral morphine as an alternate to codeine, which necessitates the need to find safe alternative analgesics in this treatment group.

The primary objectives of this study is to assess the safety(1) and efficacy (2) of morphine and ibuprofen in children with sleep apnea.

An interim analysis will be conducted after recruitment of 70 patients, to monitor both safety and efficacy


Options:
A: Arm Label: Naproxen Sodium (Aleve, BAY117031); Type: EXPERIMENTAL; Interventions: Drug: Naproxen Sodium (Aleve, BAY117031) | Arm Label: Ibuprofen (Advil); Type: ACTIVE_COMPARATOR; Interventions: Drug: Ibuprofen (Advil) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Naproxen Sodium (Aleve, BAY117031); Assigned to Arm(s): Naproxen Sodium (Aleve, BAY117031) | Intervention Type: DRUG; Name: Ibuprofen (Advil); Assigned to Arm(s): Ibuprofen (Advil) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Ibuprofen; Type: EXPERIMENTAL; Interventions: Drug: Ibuprofen | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Ibuprofen; Assigned to Arm(s): Ibuprofen | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
C: Arm Label: Morphine; Type: EXPERIMENTAL; Interventions: Drug: Morphine | Arm Label: Ibuprofen; Type: EXPERIMENTAL; Interventions: Drug: Ibuprofen | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Morphine | Intervention Type: DRUG; Name: Ibuprofen; Assigned to Arm(s): Ibuprofen
D: Arm Label: caldolor; Type: EXPERIMENTAL; Interventions: Drug: ibuprofen (caldolor 10 mg / kg) | Arm Label: denogan; Type: ACTIVE_COMPARATOR; Interventions: Drug: propacetamol (denogan 30 mg / kg) | Arm Label: combination; Type: EXPERIMENTAL; Interventions: Drug: ibuprofen + propacetamol | Intervention Type: DRUG; Name: ibuprofen (caldolor 10 mg / kg); Assigned to Arm(s): caldolor | Intervention Type: DRUG; Name: propacetamol (denogan 30 mg / kg); Assigned to Arm(s): denogan | Intervention Type: DRUG; Name: ibuprofen + propacetamol; Assigned to Arm(s): combination

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: This study will compare the efficacy and safety of Extended Release Tacrolimus (Advagraf®) + Sirolimus (Rapamune®), versus Extended Release Tacrolimus (Advagraf®) + Mycophenolate mofetil in Kidney Transplant Patients.


Options:
A: Arm Label: Everolimus + Low dose CsA +PD; Type: EXPERIMENTAL; Interventions: Drug: Everolimus + Low dose CsA +PD | Arm Label: Myfortic+ Standard CsA + PD; Type: ACTIVE_COMPARATOR; Interventions: Drug: Myfortic+ Standard CsA + PD | Intervention Type: DRUG; Name: Everolimus + Low dose CsA +PD; Assigned to Arm(s): Everolimus + Low dose CsA +PD | Intervention Type: DRUG; Name: Myfortic+ Standard CsA + PD; Assigned to Arm(s): Myfortic+ Standard CsA + PD
B: Arm Label: Low-dose Everolimus Group; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Cyclosporine A (CsA), Drug: Basiliximab, Drug: Corticosteroids | Arm Label: High-dose Everolimus Group; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Cyclosporine A (CsA), Drug: Basiliximab, Drug: Corticosteroids | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mycophenolic Acid (MPA), Drug: Cyclosporine A (CsA), Drug: Basiliximab, Drug: Corticosteroids | Intervention Type: DRUG; Name: Everolimus; Assigned to Arm(s): High-dose Everolimus Group, Low-dose Everolimus Group | Intervention Type: DRUG; Name: Mycophenolic Acid (MPA); Assigned to Arm(s): Control Group | Intervention Type: DRUG; Name: Cyclosporine A (CsA); Assigned to Arm(s): Control Group, High-dose Everolimus Group, Low-dose Everolimus Group | Intervention Type: DRUG; Name: Basiliximab; Assigned to Arm(s): Control Group, High-dose Everolimus Group, Low-dose Everolimus Group | Intervention Type: DRUG; Name: Corticosteroids; Assigned to Arm(s): Control Group, High-dose Everolimus Group, Low-dose Everolimus Group
C: Arm Label: Mycophenolate sodium; Type: ACTIVE_COMPARATOR; Interventions: Drug: Induction therapy with Thymoglobulin, prednisone, mycophenolate sodium and late introduction of tacrolimus | Arm Label: Everolimus; Type: EXPERIMENTAL; Interventions: Drug: Induction therapy with Thymoglobulin, prednisone, everolimus and late introduction of tacrolimus | Intervention Type: DRUG; Name: Induction therapy with Thymoglobulin, prednisone, everolimus and late introduction of tacrolimus; Assigned to Arm(s): Everolimus | Intervention Type: DRUG; Name: Induction therapy with Thymoglobulin, prednisone, mycophenolate sodium and late introduction of tacrolimus; Assigned to Arm(s): Mycophenolate sodium
D: Arm Label: A) TEST; Type: ACTIVE_COMPARATOR; Interventions: Drug: A) TEST, Drug: B) CONTROL | Arm Label: B) CONTROL; Type: EXPERIMENTAL; Interventions: Drug: A) TEST, Drug: B) CONTROL | Intervention Type: DRUG; Name: A) TEST; Assigned to Arm(s): A) TEST, B) CONTROL | Intervention Type: DRUG; Name: B) CONTROL; Assigned to Arm(s): A) TEST, B) CONTROL

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Global Network for Women's and Children's Health Research Does Implementation of HELPING BABIES BREATHE (HBB) Save Lives?
Brief Summary: The primary purpose of this pre-post evaluation is to test the impact on perinatal mortality (fresh stillbirths or early neonatal deaths) among births \> 1500g of training birth attendants at health facilities in the Helping Babies Breathe (HBB) and Essential Newborn Care (ENC) curricula. These facilities are located within clusters in the Global Network for Women's and Children's Health Research sites in Belgaum and Nagpur, India, and Eldoret, Kenya.


Options:
A: Arm Label: NRP Training (Intervention); Type: EXPERIMENTAL; Interventions: Procedure: Neonatal Resuscitation | Arm Label: Control; Type: OTHER; Interventions: Procedure: Neonatal Resuscitation | Intervention Type: PROCEDURE; Name: Neonatal Resuscitation; Assigned to Arm(s): Control, NRP Training (Intervention)
B: Arm Label: Facilities; Type: OTHER; Interventions: Other: HBB/ENC supplies | Arm Label: Master Trainers; Type: OTHER; Interventions: Behavioral: HBB/ENC Training and Equipment | Arm Label: Facilitators; Type: OTHER; Interventions: Behavioral: HBB/ENC Training and Equipment | Arm Label: Learners; Type: OTHER; Interventions: Behavioral: HBB/ENC Training and Equipment | Intervention Type: BEHAVIORAL; Name: HBB/ENC Training and Equipment; Assigned to Arm(s): Facilitators, Learners, Master Trainers | Intervention Type: OTHER; Name: HBB/ENC supplies; Assigned to Arm(s): Facilities
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: PRONTO training; Type: EXPERIMENTAL; Interventions: Other: PRONTO training | Intervention Type: OTHER; Name: PRONTO training; Assigned to Arm(s): PRONTO training
D: Arm Label: intervention; Type: EXPERIMENTAL; Interventions: Other: Neonatal resuscitation protocol | Arm Label: control; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard of care | Intervention Type: OTHER; Name: Neonatal resuscitation protocol; Assigned to Arm(s): intervention | Intervention Type: OTHER; Name: Standard of care; Assigned to Arm(s): control

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: EPVent 2- A Phase II Study of Mechanical Ventilation Directed by Transpulmonary Pressures (EPVent2)
Brief Summary: This phase II multi-centered, randomized controlled trial of mechanical ventilation directed by esophageal pressure measurement will test the primary hypothesis that using a strategy of maintaining a minimal but positive transpulmonary pressure (Ptp = airway pressure minus pleural pressure) throughout the ventilatory cycle will lead to an improvement in patient survival.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Different Mechanical Ventilation Protocols | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Different Mechanical Ventilation Protocols | Intervention Type: OTHER; Name: Different Mechanical Ventilation Protocols; Assigned to Arm(s): 1, 2
B: Arm Label: Focal ARDS; Type: EXPERIMENTAL; Interventions: Procedure: Mechanical ventilation | Arm Label: non focal ARDS; Type: OTHER; Interventions: Procedure: Mechanical ventilation | Intervention Type: PROCEDURE; Name: Mechanical ventilation; Assigned to Arm(s): Focal ARDS, non focal ARDS
C: Arm Label: EPVent; Type: EXPERIMENTAL; Interventions: Other: Esophageal-pressure guided mechanical ventilation | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: High PEEP mechanical ventilation | Intervention Type: OTHER; Name: Esophageal-pressure guided mechanical ventilation; Assigned to Arm(s): EPVent | Intervention Type: OTHER; Name: High PEEP mechanical ventilation; Assigned to Arm(s): Control
D: Intervention Type: PROCEDURE; Name: Control Ventilation Strategy; Assigned to Arm(s): N/A

Answer: C